About: http://data.cimple.eu/news-article/590555dc9fb655af1f97722684a0ed0ea77d74b729f07d51390e1d43

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/590555dc9fb655af1f97722684a0ed0ea77d74b729f07d51390e1d43 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Tokyo's benchmark Nikkei index jumped more than 2.2 percent on Monday following rallies in the US and Asia on fresh hopes for coronavirus treatments. The Nikkei 225 index was up 2.22 percent, or 493.93 points, to close at 22,784.74, while the broader Topix index surged 2.46 percent, or 37.82 points, to 1,573.02. Japanese shares opened higher on gains in US shares, with investors encouraged by news of progress in the development of coronavirus vaccines and treatment, brokers said. On Wall Street, investors cheered remarks from the head of German biotech firm BioNTech to the Wall Street Journal that a vaccine candidate would be ready for regulatory review by the end of the year. Analysts also pointed to a positive announcement from Gilead Sciences about clinical trials on remdesivir, a drug treatment for coronavirus. Tokyo shares rose further in afternoon trade "as investors were encouraged by gains in other Asian markets," said Shinichi Yamamoto, a broker at Okasan Securities in Tokyo. Looking ahead, investors are watching China's June trade account and second quarter GDP data due on Tuesday and Thursday respectively, and the Bank of Japan's policy decision on Wednesday, among others, analysts said. The dollar fetched 106.85 yen in Asian afternoon trade against 106.91 yen in New York on Friday. Among major winners in Tokyo, Canon jumped 5.15 percent to 2,110.5 yen and Mazda soared 8.75 percent to 683 yen on bargain-hunting. SoftBank Group surged 4.22 percent to 6,532 yen and Sony was up 4.11 percent at 8,100 yen. But Fujifilm edged down 0.06 percent to 4,636 yen after a clinical study of anti-flu drug Avigan, developed by its subsidiary, failed to show a clear efficacy in treating coronavirus patients. si/sah/je
schema:headline	Tokyo's Nikkei closes up more than 2.2 percent
schema:mentions	Favipiravir Sony USA Gymnastics Remdesivir The Wall Street Journal Asia United States dollar Gross domestic product Japan New York City Vaccine China Severe acute respiratory syndrome coronavirus 2 5:15 Mazda Fujifilm Gilead Sciences The Nikkei SoftBank Group Japanese yen Nikkei 225 Tokyo Stock Exchange
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-07-13 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	49 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software